Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate

ClinicalTrials.gov ID: NCT04511702

Public ClinicalTrials.gov record NCT04511702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multicenter, Open-Label, Infusion Duration Study To Assess Safety, Tolerability and Efficacy of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate

Study identification

NCT ID
NCT04511702
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
191 participants

Conditions and interventions

Interventions

  • Pegloticase with MTX Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 1, 2020
Primary completion
Jan 17, 2024
Completion
Mar 24, 2024
Last update posted
Oct 19, 2025

2020 – 2024

United States locations

U.S. sites
39
U.S. states
17
U.S. cities
36
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Orthopedic Physicians Alaska Anchorage Alaska 99508
Arizona Arthritis & Rheumatology Research Gilbert Arizona 85297
Arthritis & Rheumatology Research Mesa Arizona 85210
Arizona Arthritis & Rheumatology Research Phoenix Arizona 85037
Medvin Clinical Research Covina California 91722
Amicis Research Center Northridge California 91324
Providence Saint John's Health Center Santa Monica California 90404
Medvin Clinical Research Thousand Oaks California 91360
Medvin Clinical Research Tujunga California 91042
University of Colorado Division of Rheumatology Aurora Colorado 80045
Denver Arthritis Clinic Denver Colorado 80230
Bradenton Research Center Bradenton Florida 34205
Prohealth Research Center Doral Florida 33166
LIFE Clinical Trials Margate Florida 33063
D&H National Research Centers Miami Florida 33155
IRIS Research and Development, LLC Plantation Florida 33324
Napa Research Center Pompano Beach Florida 33064
D&H Tamarac Research Centers Tamarac Florida 33321
GCP Clinical Research Tampa Florida 33064
ClinPro Research Solutions Tampa Florida 33609
ForCare Clinical Research Tampa Florida 33613
MedPharmics, LLC Metairie Louisiana 70006
MD Medical Research Oxon Hill Maryland 20745
Santa Fe Rheumatology Santa Fe New Mexico 87505
Long Island Arthritis & Osteoporosis Care Babylon New York 11702
Research Carolina Elite Denver North Carolina 28037
PMG Research of Hickory, LLC Hickory North Carolina 28602
Cape Fear Arthritis Care Leland North Carolina 28451
PMG Research of Salisbury, LLC Salisbury North Carolina 28144
Shelby Clinical Research, LLC Shelby North Carolina 28150
Velocity Clinical Research Cincinnati Cincinnati Ohio 45242
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Chattanooga Research & Medicine PLLC (CHARM) Chattanooga Tennessee 37404
Abigail Rebecca Neiman, MD, PA Houston Texas 77024
Pioneer Research Solutions Inc - Houston Houston Texas 77099
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088
Western Washington Medical Group Bothell Washington 98021
Arthritis Northwest Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04511702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04511702 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →